Workflow
ReWalk(RWLK)
icon
Search documents
ReWalk(RWLK) - 2024 Q3 - Quarterly Report
2024-11-12 14:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36612 Lifeward Ltd. (Exact name of registrant as specified in charter) Israel Not applicable | --- | --- | |-------------------------- ...
ReWalk(RWLK) - 2024 Q3 - Quarterly Results
2024-11-12 13:15
Exhibit 99.1 Lifeward Ltd. Reports Third Quarter 2024 Financial Results Second consecutive quarter of 20 ReWalk systems sold Robust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim submission with Medicare and other U.S. payors MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, November 12, 2024 – Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, today announced its fi ...
ReWalk(RWLK) - 2024 Q2 - Quarterly Results
2024-08-15 12:15
Exhibit 99.1 Lifeward Reports Second Quarter 2024 Financial Results Record ReWalk revenue with 20 systems placed Q2'24 revenue of $6.7M up over 400% compared to $1.3M in Q2'23 Medicare claims for submissions from prior quarters beginning to be paid MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, August 15, 2024 – ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recove ...
ReWalk(RWLK) - 2024 Q2 - Quarterly Report
2024-08-14 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _________ Commission File Number: 001-36612 ReWalk Robotics Ltd. (Exact name of registrant as specified in charter) Israel Not applicable | --- | --- | --- | |-------- ...
ReWalk(RWLK) - 2024 Q1 - Quarterly Report
2024-05-15 13:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _________ Commission File Number: 001-36612 ReWalk Robotics Ltd. (Exact name of registrant as specified in charter) Israel Not applicable | --- | --- | --- | |------- ...
ReWalk(RWLK) - 2024 Q1 - Quarterly Results
2024-05-15 12:15
Exhibit 99.1 Lifeward Reports First Quarter 2024 Financial Results Q1'24 revenue of $5.3M is up 340% vs. Q1'23 and at the midpoint of Lifeward's guidance range Newly established Medicare payment for ReWalk Personal Exoskeleton favorably impacts Q1'24 results Medicare Administrative Contractors ("MACs") approve 14 claims since fee schedule established MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, May 15, 2024 – ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market ...
ReWalk(RWLK) - 2023 Q4 - Annual Report
2024-02-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT OR SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-36612 ReWalk Robotics Ltd. (Exact name of registrant as specified in charter) | --- | --- | |------------------------------------ ...
ReWalk(RWLK) - 2023 Q4 - Annual Results
2024-02-26 16:00
Exhibit 99.1 Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results Highest quarterly and annual revenue in the history of Lifeward Commercial and operational integration complete; synergies expected to yield $3 million in annual net savings MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, February 27, 2024 – ReWalk Robotics Ltd. (DBA Lifeward™), (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitatio ...
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
Newsfilter· 2024-01-29 13:00
Lifeward brand reflects the Company's commitment to pioneering innovative technology to empower the pursuit of life's ambitions in the face of physical limitation or disability The complete rebrand includes new name, stock ticker, logo, website launch, and corporate messaging MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 29, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk") today unveiled its new corporate branding to officially begin doing business as Lifeward™ ("Lifewa ...
ReWalk Robotics Expands Direct Sales Coverage to Canada
Newsfilter· 2024-01-12 13:30
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (NASDAQ:RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that the Company is expanding its direct sales coverage to Canada. This expansion occurs as the result of the integration between the former ReWalk and AlterG commercial teams follow ...